Literature DB >> 28213471

Attenuation of endoplasmic reticulum stress by caffeine ameliorates hyperoxia-induced lung injury.

Ru-Jeng Teng1, Xigang Jing2, Teresa Michalkiewicz2, Adeleye J Afolayan2, Tzong-Jin Wu2, Girija G Konduri2.   

Abstract

Rodent pups exposed to hyperoxia develop lung changes similar to bronchopulmonary dysplasia (BPD) in extremely premature infants. Oxidative stress from hyperoxia can injure developing lungs through endoplasmic reticulum (ER) stress. Early caffeine treatment decreases the rate of BPD, but the mechanisms remain unclear. We hypothesized that caffeine attenuates hyperoxia-induced lung injury through its chemical chaperone property. Sprague-Dawley rat pups were raised either in 90 (hyperoxia) or 21% (normoxia) oxygen from postnatal day 1 (P1) to postnatal day 10 (P10) and then recovered in 21% oxygen until P21. Caffeine (20 mg/kg) or normal saline (control) was administered intraperitoneally daily starting from P2. Lungs were inflation-fixed for histology or snap-frozen for immunoblots. Blood caffeine levels were measured in treated pups at euthanasia and were found to be 18.4 ± 4.9 μg/ml. Hyperoxia impaired alveolar formation and increased ER stress markers and downstream effectors; caffeine treatment attenuated these changes at P10. Caffeine also attenuated the hyperoxia-induced activation of cyclooxygenase-2 and markers of apoptosis. In conclusion, hyperoxia-induced alveolar growth impairment is mediated, in part, by ER stress. Early caffeine treatment protects developing lungs from hyperoxia-induced injury by attenuating ER stress.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  apoptosis; bronchopulmonary dysplasia; endoplasmic reticulum; hyperoxia; mitochondria

Mesh:

Substances:

Year:  2017        PMID: 28213471      PMCID: PMC5451596          DOI: 10.1152/ajplung.00405.2016

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   6.011


  53 in total

1.  Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta.

Authors:  T Nakagawa; H Zhu; N Morishima; E Li; J Xu; B A Yankner; J Yuan
Journal:  Nature       Date:  2000-01-06       Impact factor: 49.962

Review 2.  Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease.

Authors:  Bernard Thébaud; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2007-02-01       Impact factor: 21.405

3.  An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure.

Authors:  Connie C W Hsia; Dallas M Hyde; Matthias Ochs; Ewald R Weibel
Journal:  Am J Respir Crit Care Med       Date:  2010-02-15       Impact factor: 21.405

Review 4.  ER stress-induced inflammation: does it aid or impede disease progression?

Authors:  Abhishek D Garg; Agnieszka Kaczmarek; Olga Krysko; Peter Vandenabeele; Dmitri V Krysko; Patrizia Agostinis
Journal:  Trends Mol Med       Date:  2012-08-08       Impact factor: 11.951

Review 5.  Functional and morphological impact of ER stress on mitochondria.

Authors:  Kayleen Vannuvel; Patricia Renard; Martine Raes; Thierry Arnould
Journal:  J Cell Physiol       Date:  2013-09       Impact factor: 6.384

6.  Measuring ER stress and the unfolded protein response using mammalian tissue culture system.

Authors:  Christine M Oslowski; Fumihiko Urano
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

7.  Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats.

Authors:  H Deng; S N Mason; R L Auten
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

8.  Pharmacological activation of AMPK prevents Drp1-mediated mitochondrial fission and alleviates endoplasmic reticulum stress-associated endothelial dysfunction.

Authors:  Jia Li; Yilei Wang; Yapu Wang; Xiaodong Wen; Xiao-Nan Ma; Weijie Chen; Fang Huang; Junping Kou; Lian-Wen Qi; Baolin Liu; Kang Liu
Journal:  J Mol Cell Cardiol       Date:  2015-07-18       Impact factor: 5.000

Review 9.  Pulmonary hypertension in bronchopulmonary dysplasia.

Authors:  Sara K Berkelhamer; Karen K Mestan; Robin H Steinhorn
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

10.  Dose translation from animal to human studies revisited.

Authors:  Shannon Reagan-Shaw; Minakshi Nihal; Nihal Ahmad
Journal:  FASEB J       Date:  2007-10-17       Impact factor: 5.191

View more
  31 in total

1.  Acute and chronic changes in the control of breathing in a rat model of bronchopulmonary dysplasia.

Authors:  Gary C Mouradian; Santiago Alvarez-Argote; Ryan Gorzek; Gabriel Thuku; Teresa Michkalkiewicz; Margaret T T Wong-Riley; Girija Ganesh Konduri; Matthew R Hodges
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-01-17       Impact factor: 5.464

2.  Association Between Early Caffeine Citrate Administration and Risk of Acute Kidney Injury in Preterm Neonates: Results From the AWAKEN Study.

Authors:  Matthew W Harer; David J Askenazi; Louis J Boohaker; J Bryan Carmody; Russell L Griffin; Ronnie Guillet; David T Selewski; Jonathan R Swanson; Jennifer R Charlton
Journal:  JAMA Pediatr       Date:  2018-06-04       Impact factor: 16.193

3.  Endoplasmic reticulum stress response is activated in pulmonary hypoplasia secondary to congenital diaphragmatic hernia, but is decreased by administration of amniotic fluid stem cells.

Authors:  Areti Tzanetakis; Lina Antounians; Alyssa Belfiore; Qi Ma; Mark Stasiewicz; Ornella Pellerito; Augusto Zani
Journal:  Pediatr Surg Int       Date:  2018-11-01       Impact factor: 1.827

Review 4.  Mechanistic actions of oxygen and methylxanthines on respiratory neural control and for the treatment of neonatal apnea.

Authors:  Lisa Mitchell; Peter M MacFarlane
Journal:  Respir Physiol Neurobiol       Date:  2019-10-15       Impact factor: 1.931

5.  N-acetyl-lysyltyrosylcysteine amide, a novel systems pharmacology agent, reduces bronchopulmonary dysplasia in hyperoxic neonatal rat pups.

Authors:  Ru-Jeng Teng; Xigang Jing; Dustin P Martin; Neil Hogg; Aaron Haefke; Girija G Konduri; Billy W Day; Stephen Naylor; Kirkwood A Pritchard
Journal:  Free Radic Biol Med       Date:  2021-02-17       Impact factor: 7.376

6.  Moderate hyperoxia induces senescence in developing human lung fibroblasts.

Authors:  Kai You; Pavan Parikh; Karl Khandalavala; Sarah A Wicher; Logan Manlove; Binxia Yang; Annie Roesler; Ben B Roos; Jacob J Teske; Rodney D Britt; Christina M Pabelick; Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-08-14       Impact factor: 6.011

Review 7.  Mechanisms underlying a critical period of respiratory development in the rat.

Authors:  Margaret T T Wong-Riley; Qiuli Liu; Xiuping Gao
Journal:  Respir Physiol Neurobiol       Date:  2019-04-15       Impact factor: 2.821

Review 8.  The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment.

Authors:  Jennifer J P Collins; Dick Tibboel; Ismé M de Kleer; Irwin K M Reiss; Robbert J Rottier
Journal:  Front Med (Lausanne)       Date:  2017-05-22

Review 9.  Oxidative and endoplasmic reticulum stress in respiratory disease.

Authors:  Alice C-H Chen; Lucy Burr; Michael A McGuckin
Journal:  Clin Transl Immunology       Date:  2018-06-13

Review 10.  Halogen exposure injury in the developing lung.

Authors:  Dylan R Addis; Adam Molyvdas; Namasivayam Ambalavanan; Sadis Matalon; Tamas Jilling
Journal:  Ann N Y Acad Sci       Date:  2020-08-01       Impact factor: 6.499

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.